These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 3112804)
21. Thromboxane receptor activation during bronchospasm induced by platelet-activating factor. Schumacher WA; Steinbacher TE J Lipid Mediat; 1991; 4(1):97-110. PubMed ID: 1832573 [TBL] [Abstract][Full Text] [Related]
22. Platelet-activating factor-induced contraction of guinea-pig lung parenchymal strips: possible involvement of arachidonate metabolites. Del Monte M; Subissi A Naunyn Schmiedebergs Arch Pharmacol; 1988 Oct; 338(4):417-21. PubMed ID: 3149718 [TBL] [Abstract][Full Text] [Related]
23. Synergistic actions of PAF-acether and sodium arachidonate in human platelet aggregation. 1. Studies in normal human platelet rich plasma. Altman R; Scazziota A; Rouvier J; Cacchione R Thromb Res; 1986 Jul; 43(1):103-11. PubMed ID: 3014677 [TBL] [Abstract][Full Text] [Related]
24. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists. Piper PJ; Stewart AG Br J Pharmacol; 1987 Apr; 90(4):771-83. PubMed ID: 3034369 [TBL] [Abstract][Full Text] [Related]
25. Interactions of prostanoids with the platelet activating factors. Mentz P; Mentz G; Giessler C; Mest HJ Prostaglandins Leukot Essent Fatty Acids; 1992 Sep; 47(1):13-6. PubMed ID: 1279731 [TBL] [Abstract][Full Text] [Related]
26. Inhibition by azelastine of the effects of platelet-activating factor in lungs from actively sensitised guinea-pigs. Pretolani M; Lefort J; Venco C; Perrisoud D; Vargaftig BB Eur J Pharmacol; 1992 Jun; 216(2):141-7. PubMed ID: 1397002 [TBL] [Abstract][Full Text] [Related]
29. Granulocyte-macrophage colony-stimulating factor increases the synthesis of leukotriene B4 by human neutrophils in response to platelet-activating factor. Enhancement of both arachidonic acid availability and 5-lipoxygenase activation. McColl SR; Krump E; Naccache PH; Poubelle PE; Braquet P; Braquet M; Borgeat P J Immunol; 1991 Feb; 146(4):1204-11. PubMed ID: 1846895 [TBL] [Abstract][Full Text] [Related]
30. Effect of BN 52256 and other mediator antagonists on ouabain-induced ventricular fibrillation in sensitized guinea-pigs and on ischemia-induced fibrillation in rats. Mest HJ; Rein T; Riedel A; Köpernik W; Braquet C Agents Actions Suppl; 1992; 37():228-34. PubMed ID: 1632298 [TBL] [Abstract][Full Text] [Related]
32. Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock. Quinn JV; Slotman GJ Crit Care Med; 1999 Nov; 27(11):2485-94. PubMed ID: 10579269 [TBL] [Abstract][Full Text] [Related]
33. Mediators of injury in neurotrauma: intracellular signal transduction and gene expression. Bazan NG; Rodriguez de Turco EB; Allan G J Neurotrauma; 1995 Oct; 12(5):791-814. PubMed ID: 8594208 [TBL] [Abstract][Full Text] [Related]
34. Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues. Stimler NP; O'Flaherty JT Am J Pathol; 1983 Oct; 113(1):75-84. PubMed ID: 6624879 [TBL] [Abstract][Full Text] [Related]
35. Influence of aminophylline and ketotifen in comparison to the lipoxygenase inhibitors NDGA and esculetin and the PAF antagonists WEB 2170 [correction of 2107] and BN 52021 on endothelin-1 induced vaso- and bronchoconstriction. Lueddeckens G; Becker K; Rappold R; Förster W Prostaglandins Leukot Essent Fatty Acids; 1991 Nov; 44(3):155-8. PubMed ID: 1808625 [TBL] [Abstract][Full Text] [Related]
36. Amplification of primary response of human platelets to platelet-activating factor: aspirin-sensitive and aspirin-insensitive pathways. Lauri D; Cerletti C; de Gaetano G J Lab Clin Med; 1985 Jun; 105(6):653-8. PubMed ID: 3923145 [TBL] [Abstract][Full Text] [Related]
37. Antiarrhythmic effect of the selective I1-imidazoline receptor modulator moxonidine on ouabain-induced cardiac arrhythmia in guinea pigs. Mest HJ; Thomsen P; Raap A Ann N Y Acad Sci; 1995 Jul; 763():620-33. PubMed ID: 7677382 [TBL] [Abstract][Full Text] [Related]
38. Platelet activating factor and tracheobronchial respiratory glycoconjugate release in feline and human explants: involvement of the lipoxygenase pathway. Lundgren JD; Kaliner M; Logun C; Shelhamer JH Agents Actions; 1990 Jun; 30(3-4):329-37. PubMed ID: 2117336 [TBL] [Abstract][Full Text] [Related]
39. Contributions of thromboxane and leukotrienes to PAF-induced impairment of lung function in the rat. Uhlig S; Wollin L; Wendel A J Appl Physiol (1985); 1994 Jul; 77(1):262-9. PubMed ID: 7961243 [TBL] [Abstract][Full Text] [Related]
40. Contribution of platelets and platelet-activating factor (PAF) to the arrhythmogenic, haemodynamic and necrotic effects of acute myocardial ischaemia. Chakrabarty S; Thomas P; Sheridan DJ Eur Heart J; 1991 May; 12(5):583-9. PubMed ID: 1874258 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]